Infectious disease surveillance summary, 2014 data
The most commonly reported diseases in 2014 were chlamydia infection, campylobacteriosis, salmonellosis, gonorrhoea and tuberculosis.
Antimicrobial resistance surveillance in Europe 2011
This report presents antimicrobial resistance data for seven invasive pathogens of major public health importance: Streptococcus pneumoniae, Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Enterococcus faecium, Klebsiella pneumoniae and Pseudomonas aeruginosa.
European surveillance of Clostridium difficile infections - surveillance protocol version 2.3
This updated protocol prescribes the methodology, and provides the data collection tools required to achieve the objectives of European surveillance of CDIs.
Rapid risk assessment: Risk related to the use of ‘do-it-yourself' CRISPR-associated gene engineering kit contaminated with pathogenic bacteria
On 24 March 2017, the German authorities reported the contamination of a ‘do-it-yourself’ bacterial gene engineering CRISPR kit produced in the US. This publication assesses the risk related to the use of ‘do-it-yourself’ CRISPR-associated gene engineering kit contaminated with pathogenic bacteria.
Annual Epidemiological Report 2010 [2008 data]
The fourth edition of the Annual Epidemiological Report on Communicable Diseases in Europe provides a comprehensive summary of surveillance data for 2008.
- Antimicrobial resistance
- Avian influenza virus
- Emerging disease
- Food- and waterborne diseases
- Healthcare-associated infections
- HIV infection
- Influenza in humans, avian origin
- Influenza in humans, seasonal
- Sexually transmitted infections
- Vaccine preventable diseases
- Vector-borne disease
ECDC, EFSA and EMA Joint Scientiﬁc Opinion on a list of outcome indicators as regards surveillance of antimicrobial resistance and antimicrobial consumption in humans and food-producing animals
ECDC, EFSA and EMA have jointly established a list of harmonised outcome indicators to assist EU Member States in assessing their progress in reducing the use of antimicrobials and antimicrobial resistance (AMR) in both humans and food-producing animals.
ECDC country visit to Luxembourg to discuss antimicrobial resistance issues
An ECDC team conducted visits and meetings to the country on 29 May - 2 June 2017, with the objective of providing an evidence-based assessment of the situation. Antibiotic consumption in Luxembourg is at the EU average in hospitals, but higher than the EU average in the community. The AMR levels in bacterial isolates from humans are at or below the EU average.
ECDC country visit to Spain to discuss antimicrobial resistance issues
On 15-19 February 2016 an ECDC team conducted visits and meetings to discuss AMR issues in Spain, with the overall objective of providing an evidence-based assessment of the situation in Spain. The AMR situation in Spain poses a major public health threat to the country. Antimicrobial consumption in primary care and hospitals is among the highest in the EU/EEA and infection prevention and control and environmental cleaning measures vary significantly among hospitals and units.
ECDC country visit to Latvia to discuss antimicrobial resistance issues
As part of an ECDC country visit to Latvia on 26–30 September 2011, an ECDC team conducted visits and meetings to discuss AMR issues in Latvia and provide an assessment. Compared with many other EU countries, the present AMR situation of Latvia is favourable. There is an infection control legislation that is under implementation and the legislation is a good basis for improving infection control practices.